top of page
Decoding Neurological Disease. Building Medicines.
Translating complex neurobiology into actionable phenomic signatures. We integrate bioprinted neuro-mimetic modeling, multi-omics, and AI to develop disease-modifying therapies for CMT1A and other neurological disorders.
Targeting CMT1A Root Cause
We are advancing a robust multi-modality pipeline of precision therapies for CMT1A—the most common inherited peripheral neuropathy. Our highly optimized small molecules and bioconjugates are designed to reverse the core disease pathology and restore peripheral nerve function.
bottom of page